Prodromal and Early Parkinsonism Alpha-Synuclein Study

Go Back to All Clinical Trials

Prodromal and Early Parkinsonism Alpha-Synuclein Study

Brief description of study

The purpose of this research study is to collect samples of blood, cerebrospinal fluid (CSF, the fluid that surrounds the brain and spinal cord), skin, oral surfaces or fluids for testing of new ways to detect abnormal alpha-synuclein, a major protein involved in diseases such as Parkinson’s disease, in order to improve early diagnosis of alpha-synuclein abnormality in people with Parkinson’s disease or people at risk for Parkinson’s disease.

Clinical Study Identifier: s21-01673

Principal Investigator: Un Kang.

Other Investigators: Giulietta Maria Riboldi, Patricio Alejandro Millar Vernetti, Maria Alejandra Gonzalez-Duarte Briseno, Horacio Kaufmann, Thong C Ma.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies